StoryCompare

THE BRIEF

Trastuzumab Rezetecan Reduces Breast Cancer Progression

A phase 3 trial published in JAMA found trastuzumab rezetecan cut progression or death risk by 73% in advanced breast cancer.

THE BRIEF

WHAT'S REPORTED

  • ▸Phase 3 clinical trial published in JAMA found trastuzumab rezetecan linked to 73% lower risk of cancer progression or death versus chemotherapy. — Fox News Health

Keep reading

THE BRIEF
Today
HEALTHTHE BRIEF

Judge Blocks Medicaid Work Requirement Rule

A federal judge blocked the Trump administration's Medicaid work requirement rule requiring proof of medical frailty.

WHAT'S REPORTED

  • ▸Twenty-five states sued the Trump administration in June over Centers for Medicare and Medicaid Services guidance tied to the 2025 law known as the 'One Big Beautiful Bill.' — PBS NewsHour Health
THE BRIEF
Today
HEALTHTHE BRIEF

Bodum French Press Coffee Maker Recall

Bodum recalled nearly 6 million French press coffee makers over burn risk from breaking glass carafes.

WHAT'S REPORTED

  • ▸Bodum recalled nearly 6 million French press coffee makers after reports of the glass carafe breaking and burning consumers. — NBC News Health